Ownership history in Prosight Management, LP · 14 quarters on record
This page tracks every 13F SEC filing in which Prosight Management, LP reported a position in ADC THERAPEUTICS SA (ADCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 8,477,338 | +1,005,035 | +13.5% | 6.18% | $29.9M | $3.53 |
| 2025 Q3 | REDUCED | 7,472,303 | -2,995,468 | -28.6% | 6.97% | $29.9M | $4.00 |
| 2025 Q2 | ADDED | 10,467,771 | +924,767 | +9.7% | 6.84% | $28.1M | $2.68 |
| 2025 Q1 | ADDED | 9,543,004 | +28,004 | +0.3% | 4.42% | $13.5M | $1.41 |
| 2024 Q4 | REDUCED | 9,515,000 | -121,237 | -1.3% | 5.23% | $18.9M | $1.99 |
| 2024 Q3 | ADDED | 9,636,237 | +66,237 | +0.7% | 7.47% | $30.4M | $3.15 |
| 2024 Q2 | ADDED | 9,570,000 | +2,519,700 | +35.7% | 9.04% | $30.2M | $3.16 |
| 2024 Q1 | ADDED | 7,050,300 | +578,500 | +8.9% | 8.81% | $31.7M | $4.49 |
| 2023 Q4 | ADDED | 6,471,800 | +1,069,759 | +19.8% | 4.31% | $10.7M | $1.66 |
| 2023 Q3 | REDUCED | 5,402,041 | -181,859 | -3.3% | 1.54% | $4.8M | $0.90 |
As of 2025 Q4 — sorted by position size